5-Fu Plus Epirubicin is Superior to Standard 5-FU Plus Cisplatin and Epirubicin in the Neoadjuvant Gastric Cancer Spheroid Model

表阿霉素 伊立替康 医学 奥沙利铂 顺铂 内科学 癌症 肿瘤科 联合疗法 化疗 药理学 泌尿科 结直肠癌 乳腺癌
作者
I Nengah Wiadnyana Steven Christian,Mareile Joka,von hn-Rotfelser De Karin,Jörg Schirra,Jens Werner,Barbara Mayer
出处
期刊:Annals of Oncology [Elsevier BV]
卷期号:25: ii17-ii17
标识
DOI:10.1093/annonc/mdu165.13
摘要

Introduction: 5-fluorouracil combined with Cisplatin and Epirubicin (FCE) is a well-accepted standard therapy in neoadjuvant gastric cancer. However, a number of side effects are observed for this combination therapy in a large portion of the patient cohorts. This raises the question whether a different backbone using Oxaliplatin or Irinotecan or even a doublet combination is equally effective as the FCE treatment regimen. Methods: The combination therapies 5-FU plus either Cisplatin, Oxaliplatin or Irinotecan (FC, FO and FI), with or without the addition of Epirubicin (FCE, FOE and FIE), as well as Epirubicin as monotherapy and in combination with 5-FU (FE) were analysed in a three-dimensional multicellular tumor spheroid model derived from patient tumor samples. Surgical material or tissue biopsies of 22 gastric cancer patient tumors were processed in vitro for the direct formation of multicellular tumor spheroids. After 48h, treatment with the intended chemotherapeutic drug combinations was conducted. Treatment efficacy was measured after further 48h using the ATP assay and expressed as residual metabolic activity in per cent of solvent control. For Statistical analysis, Kolmogorov-Smirnov test for normal distribution and Mann-Whitney-U test was performed. Results: Of the three doublet combination therapies FC, FO and FI, the most effective treatment FC statistically showed a tendency to be superior to FO (p = 0,067; 35,87% vs. 45,38% residual metabolic activity) and was significantly superior to FI (p = 0,002; 53,29% residual metabolic activity). When adding Epirubicin to each of the combinations, the three treatments FCE, FOE and FIE were equally effective (29,34%, 29,28% and 27,64% residual metabolic activity, respectively), suggesting that Epirubicin has the strongest effect on the therapeutic efficacy of the triplet combinations. Three of the patient tumor samples were additionally tested in this respect and revealed a significantly lower efficacy of Epirubicin alone in comparison to the other Epirubicin-containing regimens (p = 0,002). A comparable therapeutic efficacy to the triplet combinations FCE, FOE and FIE was achieved with the FE doublet combination (patient #1: 20,37% FCE, FOE, FIE vs. 23,68% FE; patient #2: 3,83% FCE, FOE, FIE vs. 6,91% FE and patient #3: 15,25% FCE, FOE, FIE vs. 24,75% FE, respectively). Conclusion: The triplet combinations with Epirubicin all had similar therapeutic efficacies in vitro although their corresponding backbones without Epirubicin show different efficacies. The hypothesis that Epirubicin has the largest impact on the overall efficacy of the regimen was confirmed for three patient samples by the efficacy of the doublet combination FE which was as effective as each of the Epirubicin triplet combinations. As treatment regimens with less drug components potentially have fewer side effects for the patients, especially when removing a platinum component, gastric cancer patients might benefit from the FE combination treatment.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
1秒前
深情安青的应助被小白采纳,获得10
1秒前
CaliU发布了新的文献求助10
1秒前
搜集达人的应助被Daangxi采纳,获得10
1秒前
lk发布了新的文献求助10
2秒前
所所的应助被困就睡觉采纳,获得10
2秒前
lyhh完成签到,获得积分10
2秒前
2秒前
英姑的应助被忧郁的鱿鱼采纳,获得10
2秒前
风趣的鼠标完成签到,获得积分10
3秒前
Color完成签到,获得积分10
3秒前
甜甜发布了新的文献求助10
3秒前
FashionBoy的应助被yy采纳,获得10
4秒前
墨辞完成签到,获得积分10
4秒前
4秒前
4秒前
4秒前
可爱觅松发布了新的文献求助10
4秒前
4秒前
田様的应助被明理鸿采纳,获得10
4秒前
秋风的应助被wyk采纳,获得10
4秒前
杀出个黎明举报求助违规成功
5秒前
Anonymous举报求助违规成功
5秒前
MchemG举报求助违规成功
5秒前
Ren的应助被朋友需要采纳,获得200
5秒前
脑洞疼的应助被lulululu采纳,获得10
5秒前
扶风阁主发布了新的文献求助10
5秒前
6秒前
七听的应助被番茄采纳,获得30
6秒前
6秒前
6秒前
ECCE发布了新的文献求助10
7秒前
mjq发布了新的文献求助10
7秒前
无情愫的应助被体贴洋葱采纳,获得10
8秒前
8秒前
8秒前
youyouyeah发布了新的文献求助10
8秒前
WBH36323发布了新的文献求助10
8秒前
逢坂大河发布了新的文献求助10
9秒前
9秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1500
John McDowells Bildungstheorie 800
Analyses de reconnaissances de dettes passées devant les échevins d'Ypres (1249-1291) 600
Handbook of Pharmaceutical Excipients. 9th ed 400
Synthesis, Application and Future Perspectives of Smart Nano-materials - Part 1 400
Breaking the World 300
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8155737
求助须知:如何正确求助?哪些是违规求助? 9552018
关于积分的说明 21707687
捐赠科研通 7744923
什么是DOI,文献DOI怎么找? 3426177
关于科研通互助平台的介绍 2551229
邀请新用户注册赠送积分活动 2469949